Top

Diagnostic Pathology

Published in:

Open Access 01-12-2012 | Research

Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx

Authors: Yu Liu, Xiao-li Dong, Cheng Tian, Hong-gang Liu

Published in: Diagnostic Pathology | Issue 1/2012

Abstract

Background

Gain of 3q26 is frequently observed in squamous cell carcinomas of mucosal origin, including those originating in the head and neck region. The human telomerase RNA component (hTERC) gene, which is located on chromosome 3q26, encodes for an RNA subunit of telomerase that maintains the length of telomeres through cellular divisions, and is activated in malignant diseases. The present study was designed to detect hTERC amplification in laryngeal lesions and evaluate whether this might serve as a supportive biomarker in histopathological analysis for in the diagnosis of laryngeal lesions.

Methods

Fluorescent in situ hybridization (FISH) was applied on formalin-fixed paraffin-embedded blocks of 93 laryngeal specimens, including 14 normal epithelium (NE), 15 mild dysplasia (Md), 18 moderate dysplasia (MD), 16 severe dysplasia (SD), 9 carcinoma in situ (CIS), and 21 invasive carcinoma (IC)).

Results

By histopathologic examination, hTERC amplification rates in NE, Md, MD, SD, CIS and IC cases were 0% (0/14), 13.33% (2/15), 72.22% (13/18), 81.25% (13/16), 100% (9/9) and 100% (21/21), respectively. Amplification of hTERC was significantly associated with histopathologic diagnosis (P < 0.0001). The percentage of hTERC amplification in patients with MD, SD, CIS, and IC was significantly higher than those with NE or Md (P < 0.0001). The number of cells with abnormal signals increased and the abnormal signal patterns were diversified with increasing severity of laryngeal dysplasia (P < 0.0001).

Conclusions

The hTERC amplification is important in the development of laryngeal squamous cell carcinoma (LSCC). FISH detection of hTERC amplification may provide an effective approach in conjunction with histopathologic evaluation for differential diagnosis of laryngeal lesions.

Virtual Slides

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2226606266791985

Available only for authorised users

Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G, Lefebvre JL: Cancer of the larynx. Crit Rev Oncol Hematol. 2003, 47: 65-80. 10.1016/S1040-8428(03)00017-9.CrossRefPubMed

Mao L, Hong WK, Papadimitrakopoulou VA: Focus on head and neck cancer. Cancer Cell. 2004, 5: 311-316. 10.1016/S1535-6108(04)00090-X.CrossRefPubMed

Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005. CA Cancer J Clin. 2005, 55: 10-30. 10.3322/canjclin.55.1.10.CrossRefPubMed

Sugita M, Tanaka N, Davidson S, Sekiya S, Varella-Garcia M, West J, Drabkin HA, Gemmill RM: Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet. 2000, 117: 9-18. 10.1016/S0165-4608(99)00135-1.CrossRefPubMed

Yokoi S, Yasui K, Iizasa T, Imoto I, Fujisawa T, Inazawa J: TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. Clin Cancer Res. 2003, 9: 4705-4713.PubMed

Fan YB, Ye L, Wang TY, Wu GP: Correlation between morphology and human telomerase gene amplification in bronchial brushing cells for the diagnosis of lung cancer. Diagn Cytopathol. 2010, 38: 402-406. 10.1002/dc.21235.CrossRefPubMed

Hermsen M, Guervos MA, Meijer G, Baak J, van Diest P, Marcos CA, Sampedro A: New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridization. J Pathol. 2001, 194: 177-182. 10.1002/path.862.CrossRefPubMed

Singh B, Stoffel A, Gogineni S, Poluri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, Rao PH: Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol. 2002, 161: 365-371. 10.1016/S0002-9440(10)64191-0.PubMedCentralCrossRefPubMed

Ashman JN, Patmore HS, Condon LT, Cawkwell L, Stafford ND, Greenman J: Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation. Br J Cancer. 2003, 89: 864-869. 10.1038/sj.bjc.6601199.PubMedCentralCrossRefPubMed

10.

Hopman AH, Theelen W, Hommelberg PP, Kamps MA, Herrington CS, Morrison LE, Speel EJ, Smedts F, Ramaekers FC: Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol. 2006, 210: 412-419. 10.1002/path.2070.CrossRefPubMed

11.

Caraway NP, Khanna A, Dawlett M, Guo M, Guo N, Lin E, Katz RL: Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol. 2008, 110: 37-42. 10.1016/j.ygyno.2008.01.040.CrossRefPubMed

12.

Yen CC, Chen YJ, Pan CC, Lu KH, Chen PC, Hsia JY, Chen JT, Wu YC, Hsu WH, Wang LS, Huang MH, Huang BS, Hu CP, Chen PM, Lin CH: Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed. World J Gastroenterol. 2005, 11: 1267-1272.PubMedCentralCrossRefPubMed

13.

Imoto I, Yuki Y, Sonoda I, Ito T, Shimada Y, Imamura M, Inazawa J: Identification of ZASC1 encoding a Kruppel-like zinc finger protein as a novel target for 3q26 amplification in esophageal squamous cell carcinomas. Cancer Res. 2003, 63: 5691-5696.PubMed

14.

Meyerson M: Role of telomerase in normal and cancer cells. J Clin Oncol. 2000, 18: 2626-2634.PubMed

15.

Guilleret I, Yan P, Guillou L, Braunschweig R, Coindre JM, Benhattar J: The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation. Carcinogenesis. 2002, 23: 2025-2030. 10.1093/carcin/23.12.2025.CrossRefPubMed

16.

Tu Z, Zhang A, Wu R, Jiang J, Li Y, Wulan N, Li J, Zhang Y, Li Y, Chen Z, Wei L: Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders. Cancer Genet Cytogenet. 2009, 191: 10-16. 10.1016/j.cancergencyto.2009.01.004.CrossRefPubMed

17.

Jiang J, Wei LH, Li YL, Wu RF, Xie X, Feng YJ, Zhang G, Zhao C, Zhao Y, Chen Z: Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China. J Mol Diagn. 2010, 12: 808-817. 10.2353/jmoldx.2010.100021.PubMedCentralCrossRefPubMed

18.

Xiang L, Yang H, Li J, Wu X, Zhou X: Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III. Diagn Cytopathol. 2011, doi: 10.1002/dc.21635

19.

Ha PK, Califano JA: The molecular biology of laryngeal cancer. Otolaryngol Clin North Am. 2002, 35: 993-1012. 10.1016/S0030-6665(02)00038-5.CrossRefPubMed

20.

Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR: Protein composition of catalytically active human telomerase from immortal cells. Science. 2007, 315: 1850-1853. 10.1126/science.1138596.CrossRefPubMed

21.

Cao Y, Bryan TM, Reddel RR: Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci. 2008, 99: 1092-1099. 10.1111/j.1349-7006.2008.00815.x.CrossRefPubMed

22.

Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN: Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene. 1997, 14: 1013-1021. 10.1038/sj.onc.1201066.CrossRefPubMed

23.

Sasiadek M, Stembalska-Kozlowska A, Smigiel R, Krecicki T, Blin N, Mirghomizadeh F: Microsatellite and chromosome instability in squamous cell laryngeal carcinoma. Int J Oncol. 2001, 19: 401-405.PubMed

24.

Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schaffer AA, Desper R, Schantz SP: Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer. 2002, 34: 224-233. 10.1002/gcc.10062.CrossRefPubMed

25.

Hashimoto Y, Oga A, Kawauchi S, Furuya T, Shimizu N, Nakano T, Imate Y, Yamashita H, Sasaki K: Amplification of 3q26 approximately qter correlates with tumor progression in head and neck squamous cell carcinomas. Cancer Genet Cytogenet. 2001, 129: 52-56. 10.1016/S0165-4608(01)00425-3.CrossRefPubMed

26.

Patmore HS, Ashman JN, Stafford ND, Berrieman HK, MacDonald A, Greenman J, Cawkwell L: Genetic analysis of head and neck squamous cell carcinoma using comparative genomic hybridisation identifies specific aberrations associated with laryngeal origin. Cancer Lett. 2007, 258: 55-62. 10.1016/j.canlet.2007.08.014.CrossRefPubMed

27.

Taubald A, Liehr T, Ries J, Girod S, Hassfurter E, Gebhart E: CGH-detected DNA sequence copy number amplifications can be confirmed by interphase-FISH: new possiblities for prognostic approaches in oral squamous cell carcinomas. Int J Mol Med. 1998, 2: 555-560.PubMed

28.

Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I: Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol. 2000, 157: 369-375. 10.1016/S0002-9440(10)64549-X.PubMedCentralCrossRefPubMed

29.

Luzar B, Poljak M, Marin IJ, Gale N: Telomerase reactivation is an early event in laryngeal carcinogenesis. Mod Pathol. 2003, 16: 841-848. 10.1097/01.MP.0000086488.36623.27.CrossRefPubMed

30.

Luzar B, Poljak M, Gale N: Telomerase catalytic subunit in laryngeal carcinogenesis-an immunohistochemical study. Mod Pathol. 2005, 18: 406-411. 10.1038/modpathol.3800275.CrossRefPubMed

Title: Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx
Authors: Yu Liu
Xiao-li Dong
Cheng Tian
Hong-gang Liu
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: Diagnostic Pathology / Issue 1/2012
Electronic ISSN: 1746-1596
DOI: https://doi.org/10.1186/1746-1596-7-34

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx

Abstract

Background

Methods

Results

Conclusions

Virtual Slides

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Virtual Slides

Please log in to get access to this content

Other articles of this Issue 1/2012

Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data

Genetic alterations in a primary medullary thyroid carcinoma and its lymph node metastasis in a patient with 15 years follow-up

Introduction of virtual microscopy in routine surgical pathology - a hypothesis and personal view from Europe

Immunohistochemical characterization of neoplastic cells of breast origin

Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors

Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature